The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis

Molecular Carcinogenesis

Volumn 45, Issue 2, 2006, Pages 93-105

  Yerushalmi, Hagit F ^a   Besselsen, David G ^b   Ignatenko, Natalia A ^c   Blohm Mangone, Karen A ^a   Padilla Torres, Jose L ^a   Stringer, David E ^a   Cui, Haiyan ^a   Holubec, Hana ^c   Payne, Claire M ^c   Gerner, Eugene W ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Arginine; Min mice; Nos2; Nos3

Indexed keywords

3 NITROTYROSINE; ARGININE; DRINKING WATER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER MODEL; CATABOLISM; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE; GENE EXPRESSION; INTESTINE EPITHELIUM CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NOS2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMALL INTESTINE CARCINOMA; STEM CELL; TUMOR VOLUME;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; APOPTOSIS; ARGININE; COLONIC NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; INTESTINAL NEOPLASMS; INTESTINE, SMALL; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; TYROSINE;

ANIMALIA;

EID: 32044447491     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20168     Document Type: Article

References (42)

1. Agricultural Handbook: Department of Agriculture. 1-23.
2. Scott L, Lamb J, Smith S, Wheatley DN. Single amino acid (arginine) deprivation: Rapid and selective death of cultured transformed and malignant cells. Br J Cancer 2000;83:800-810.
3. Szende B, Tyihak E, Trezl L. Role of arginine and its methylated derivatives in cancer biology and treatment. Cancer Cell Int 2001;1:3.
4. Park KG, Heys SD, Blessing K, et al. Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Lond) 1992; 82:413-417.
5. Wu G, Morris SM, Jr. Arginine metabolism: Nitric oxide and beyond. Biochem J 1998;336:1-17.
6. Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 1996;114:107-132.
7. Singh R, Pervin S, Karimi A, Cederbaum S, Chaudhuri G. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res 2000; 60:3305-3312.
8. Singh R, Pervin S, Chaudhuri G. Caspase-8-mediated BID cleavage and release of mitochondrial cytochrome c during Nomega-hydroxy-L-arginine-induced apoptosis in MDA-MB-468 cells. Antagonistic effects of L-ornithine. J Biol Chem 2002;277:37630-37636.
9. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2001;2:149-156.
10. Ambs S, Merriam WG, Bennett WP, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998;58:334-341.
11. Takahashi M, Fukuda K, Ohata T, Sugimura T, Wakabayashi K. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res 1997;57:1233-1237.
12. Escribano M, Molero L, Lopez-Farre A, et al. Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development. Clin Sci (Lond) 2004;106:83-91.
13. Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 2002;62:165-170.
14. Su LK, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992;256:668-670.
15. Ahn B, Ohshima H. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res 2001;61:8357-8360.
16. Scott DJ, Hull MA, Cartwright EJ, et al. Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse. Gastroenterology 2001;121:889-899.
17. Jadeski LC, Hum KO, Chakraborty C, Lala PK. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 2000;86:30-39.
18. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res 2002;12:311-320.
19. Payne CM, Bernstein C, Bernstein H, Gerner EW, Garewal H. Reactive nitrogen species in colon carcinogenesis. Antioxid Redox Signal 1999;1:449-467.
20. Washo-Stultz D, Hoglen N, Bernstein H, Bernstein C, Payne CM. Role of nitric oxide and peroxynitrite in bile salt-induced apoptosis: Relevance to colon carcinogenesis. Nutr Cancer 1999;35:180-188.
21. Wenzel U, Kuntz S, De Sousa UJ, Daniel H. Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Int J Cancer 2003;106:666-675.
22. Payne CM, Waltmire CN, Crowley C, et al. Caspase-6 mediated cleavage of guanylate cyclase alpha 1 during deoxycholate-induced apoptosis: Protective role of the nitric oxide signaling module. Cell Biol Toxicol 2003;19:373-392.
23. Hawk CT, Leary SL, Morris TH. Formula for laboratory animals: Ames: Blackwell Publishing: 2005.
24. Venho B, Voutilainen S, Valkonen VP, et al. Arginine intake, blood pressure, and the incidence of acute coronary events in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2002;76:359-364.
25. Cress AE. Quantitation of phosphotyrosine signals in human prostate cell adhesion sites. Biotechniques 2000;29:776, 778, 780-771.
26. Viera L, Ye YZ, Estevez AG, Beckman JS. Immunohistochemical methods to detect nitrotyrosine. Methods Enzymol 1999;301:373-381.
27. Rao CV, Kawamori T, Hamid R, Reddy BS. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 1999;20:641-644.
28. Chen K, Inoue M, Okada A. Expression of inducible nitric oxide synthase mRNA in rat digestive tissues after endotoxin and its role in intestinal mucosal injury. Biochem Biophys Res Commun 1996;224:703-708.
29. Chen K, Inoue M, Wasa M, Fukuzawa M, Kamata S, Okada A. Expression of endothelial constitutive nitric oxide synthase mRNA in gastrointestinal mucosa and its downregulation by endotoxin. Life Sci 1997;61:1323-1329.
30. Lu JL, Schmiege LM III, Kuo L, Liao JC. Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Commun 1996; 225:1-5.
31. Vissers YL, Hallemeesch MM, Soeters PB, Lamers WH, Deutz NE. NOS2 deficiency increases intestinal metabolism both in nonstimulated and endotoxemic mice. Am J Physiol Gastrointest Liver Physiol 2004;286:G747-G751.
32. Ny L, Persson K, Larsson B, et al. Localization and activity of nitric oxide synthases in the gastrointestinal tract of Trypanosoma cruzi-infected mice. J Neuroimmunol 1999; 99:27-35.
33. Yoshizumi M, Perrella MA, Burnett JC, Jr., Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993; 73:205-209.
34. Gilchrist M, McCauley SD, Befus AD. Expression, localization and regulation of nitric oxide synthase (NOS) in human mast cell lines: Effects on leukotriene production. Blood 2004; 104:462-469.
35. Giordano A, Tonello C, Bulbarelli A, et al. Evidence for a functional nitric oxide synthase system in brown adipocyte nucleus. FEBS Lett 2002;514:135-140.
36. Feng Y, Venema VJ, Venema RC, Tsai N, Caldwell RB. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun 1999;256:192-197.
37. Bentz BG, Chandra R, Haines GK III, Robinson AM, Shah P, Radosevich JA. Nitric oxide and apoptosis during human head and neck squamous cell carcinoma development. Am J Otolaryngol 2002;23:4-11.
38. Gu X, El-Remessy AB, Brooks SE, Al-Shabrawey M, Tsai NT, Caldwell RB. Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol Cell Physiol 2003;285:C546-C554.
39. de la Monte SM, Chiche J, von dem Bussche A, et al. Nitric oxide synthase-3 overexpression causes apoptosis and impairs neuronal mitochondrial function: Relevance to Alzheimer's-type neurodegeneration. Lab Invest 2003;83: 287-298.
40. Stuehr DJ. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol 1997;37:339-359.
41. Lee J, Ryu H, Ferrante RJ, Morris SM, Jr., Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci USA 2003;100:4843-4848.
42. Willett WC. Diet and cancer: One view at the start of the millennium. Cancer Epidemiol Biomarkers Prev 2001;10: 3-8.